M&A Watch: Curaleaf is sweetening its hostile bid for Edmonton’s Aurora Cannabis, raising the offer to $5 per Aurora share (0.4013 Curaleaf shares plus $1 cash), as it pushes for good-faith talks after Aurora urged shareholders to reject the earlier $4 bid. Federal Hemp Shock: A $28B hemp THC business is bracing for a looming federal ban after Congress moved to close a loophole, delaying the effective date to Dec. 11 to give lawmakers more time. Medical Access Moves: Georgia regulators approved medical cannabis home delivery rules, letting licensed operators use USPS or private carriers for patient drop-offs and deliveries to long-term care facilities. Research & Safety: FDA is seeking public input on how to run early clinical research on ibogaine, focusing on study design, dosing, safety monitoring, and ethics. State Policy & Markets: Massachusetts Gov. Maura Healey urged voters to keep recreational marijuana legal by rejecting a ballot measure to roll it back, while Minnesota’s Office of Cannabis Management published real-world study results showing reduced anxiety and depression symptoms for autism patients on medical cannabis. Industry Operations: Georgia regulators also approved new rules for colleges and universities to conduct medical cannabis research using state program products. Veterans & Wellness: Cannatrol’s Cool Cure Limited Edition program added Operation Green Healing as an exclusive nonprofit partner, directing a share of sales to veterans’ wellness and education.